Indeed, JMJD1A was reported to be involved in the splicing of AR-V7 in prostate cancer cells [79] (Figure 4); mechanistically, HNRNPF was shown to interact with JMJD1A to promote this splicing event [79]. Here, KDM3A is linked to prostate carcinoma.